TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
BioStock AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
17,035
|
19,011
|
19,853 |
| Financial expenses |
2
|
10
|
18 |
| Earnings before taxes |
1,317
|
1,717
|
2,745 |
| EBITDA |
1,468
|
1,861
|
2,895 |
| Total assets |
4,871
|
5,830
|
9,732 |
| Current assets |
4,665
|
5,449
|
9,224 |
| Current liabilities |
2,256
|
2,440
|
5,283 |
| Equity capital |
2,376
|
3,151
|
4,210 |
| - share capital |
60
|
60
|
60 |
| Employees (average) |
10
|
0
|
16 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
48.8%
|
54.0%
|
43.3% |
| Turnover per employee | 1,704 | 1,241 | |
| Profit as a percentage of turnover |
7.7%
|
9.0%
|
13.8% |
| Return on assets (ROA) |
27.1%
|
29.6%
|
28.4% |
| Current ratio |
206.8%
|
223.3%
|
174.6% |
| Return on equity (ROE) |
55.4%
|
54.5%
|
65.2% |
| Change turnover |
-1,976
|
-842
|
1,657 |
| Change turnover % |
-10%
|
-4%
|
9% |
| Chg. No. of employees |
10
|
-16
|
4 |
| Chg. No. of employees % |
-100%
|
33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.